As of 9/30/2024, Tracenable has captured detailed data on SCHOTT Pharma AG & Co's corporate ownership structure, providing a comprehensive view of its downstream entities and the role within the broader group hierarchy.a
The dataset includes information on 18 affiliated entities, encompassing subsidiaries, joint ventures, associates, and other related companies in which SCHOTT Pharma AG & Co holds an equity interest or exercises control as the ultimate parent.a
Tracenable's data also records effective ownership percentages that SCHOTT Pharma AG & Co holds across these entities, providing transparency into its corporate control, ownership hierarchy, and group governance practices.a
| Entity Name | Country | Type | Ownership | LEI | PermID |
|---|---|---|---|---|---|
SCHOTT Pharma Mexico GmbHa | DEU | Subsidiary | 100% | 0000000 | 0000000 |
SCHOTT Envases Argentina S.A.a | ARG | Subsidiary | 100% | 0000000 | 0000000 |
SCHOTT Pharma Brasil Ltda.a | BRA | Subsidiary | 100% | 0000000 | 0000000 |
SCHOTT Pharmaceutical Packaging (Zhejiang) Co., Ltd.a | CHN | Subsidiary | 100% | 0000000 | 0000000 |
SCHOTT France Pharma Systems SASa | FRA | Subsidiary | 100% | 0000000 | 0000000 |
SCHOTT Pharma France SASa | FRA | Subsidiary | 100% | 0000000 | 0000000 |
PT. SCHOTT Igar Glassa | IDN | Subsidiary | 100% | 0000000 | 0000000 |
SCHOTT Envases Farmacéuticos SASa | COL | Subsidiary | 72.7% | 0000000 | 0000000 |
SCHOTT de México, S.A. de C.V.a | MEX | Subsidiary | 100% | 0000000 | 0000000 |
SCHOTT Pharmaceutical Packaging OOOa | RUS | Subsidiary | 100% | 0000000 | 0000000 |
SCHOTT forma vitrum holding aga | CHE | Subsidiary | 100% | 0000000 | 0000000 |
SCHOTT Pharma Schweiz AGa | CHE | Subsidiary | 100% | 0000000 | 0000000 |
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| Showing 12 out of 18 entities. Get complete coverage in the full dataset. | |||||
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore SCHOTT Pharma AG & Co’s data sources below and access millions more through our Disclosure Search.
Tracenable's dataset provides geographic insights into SCHOTT Pharma AG & Co's group entities, revealing where its subsidiaries, joint ventures, associates, and affiliates are located worldwide.a
In total, the SCHOTT Pharma AG & Co group consists of 18 entities distributed across 16 countries, reflecting the company's global footprint and jurisdictional presence.a
This visualization highlights the geographical distribution of SCHOTT Pharma AG & Co's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape.a
In 2024, Tracenable identified that the SCHOTT Pharma AG & Co group consisted of 18 entities operating across 16 countries.a
This indicates a moderate geographic diversification, reflecting SCHOTT Pharma AG & Co's expansion strategy, global footprint, and cross-border exposure.a
SCHOTT Pharma AG & Co's subsidiaries and affiliates are primarily concentrated in Europe and Latin America & the Caribbean, which host 66.67% of its total entities.a
This regional distribution suggests that SCHOTT Pharma AG & Co's operational and financial activities are centered in these markets, either due to core business operations, supply chain proximity, or favorable regulatory environments.
SCHOTT Pharma AG & Co shows a moderate to high level of transparency regarding its ownership structure.
The disclosure includes information on subsidiaries, joint ventures, and associates, allowing partial visibility into the company's downstream relationships and areas of shared control.a
While not a full edge-level disclosure, the data still provides meaningful insight into SCHOTT Pharma AG & Co's governance framework and group composition, positioning it among more transparent reporters in its industry.
No. Tracenable's data does not indicate any entities registered in jurisdictions typically categorized as low-tax or offshore financial centers, suggesting that SCHOTT Pharma AG & Co's ownership network is primarily domiciled in standard corporate jurisdictions or that SCHOTT Pharma AG & Co does not provide full transparency on its corporate structure.a